Cargando…
Fe(3+)@PDOPA‑b‑PSar Nanoparticles for Magnetic Resonance Imaging and Cancer Chemotherapy
PURPOSE: Chemotherapy treatments for cancer are always accompanied by a low concentration of drug delivered in the tumor area and severe side effects including systemic toxicity. Improving the concentration, biocompatibility, and biodegradability of regional chemotherapy drugs is a pressing challeng...
Autores principales: | Sun, Wei, Xu, Songyi, Shen, Tianlun, Li, Guangyao, Zhang, Jingfeng, Pan, Chunshu, Lu, Wei, Liu, Xiangrui, Zheng, Jianjun, Ling, Jun, Sun, Jihong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10149081/ https://www.ncbi.nlm.nih.gov/pubmed/37131547 http://dx.doi.org/10.2147/IJN.S393846 |
Ejemplares similares
-
PSAR: measuring multiple sequence alignment reliability by probabilistic sampling
por: Kim, Jaebum, et al.
Publicado: (2011) -
Magnetic resonance colonography with intestine-absorbable nanoparticle contrast agents in evaluation of colorectal inflammation
por: Dong, Xue, et al.
Publicado: (2021) -
Ni(2+)-Dependent and PsaR-Mediated Regulation of the Virulence Genes pcpA, psaBCA, and prtA in Streptococcus pneumoniae
por: Manzoor, Irfan, et al.
Publicado: (2015) -
Development of a Novel MR Colonography via Iron-Based Solid Lipid Nanoparticles
por: Wang, Huiyang, et al.
Publicado: (2022) -
Magnetic resonance of the NiFe(2)O(4) nanoparticles in the gigahertz range
por: Shi, Zhenhua, et al.
Publicado: (2013)